Allergy & Immunology

Filter

COVAIL Trial Reveals Insights Into Antibody Levels and Vaccine Efficacy

February 2025

New data from the COVAIL trial highlight the importance of neutralizing antibody titers in reducing COVID-19 risk after mRNA boosters, with stronger protection observed in individuals with prior SARS-CoV-2 infection.

EMJ

Genome-Wide Meta-Analysis Provides Insight into the ‘Atopic March’

SEVEN genetic risk loci have been identified for the ‘atopic march’, the sequential progression of different allergic conditions frequently seen in…

EMJ

SCHILLER Enables the Export of ECG Raw Data: Resting ECGs, Exercise ECGs and Resting Rhythms

SCHILLER’s declared goal is to make therapy-relevant data accessible in digital form throughout the hospital. Thanks to the latest development, we have…

EMJ

Dr Jim Duthie, Our #EMJExpert, Answers Your Questions for Blue September

In support of Blue September, an annual campaign designed to raise global awareness for male related cancers, we invited world-renowned urologist Dr Jim…

EMJ

TMIGD1: A Protein; an Immunoglobulin; a Protector of Kidney Cells

TRANSMEMBRANE and immunoglobulin domain-containing 1 (TMIGD1), a previously unknown protein involved in protecting kidney epithelial cells…

EMJ

European CHMP Adopts Positive Opinion for Gilead’s Single Tablet Regimen Genvoya® (Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide) for the Treatment of HIV

Foster City, CA, September XX, 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP)…

EMJ

Plans for Universal Flu Vaccine Receive Timely Boost

DREAMS of a universal flu vaccine that is effective against all flu strains are a step closer to becoming a reality thanks to the findings of a new study.

EMJ

International Coeliac Day 16 May 2014

As part of this year’s International Coeliac Day, AOECS is raising awareness for an improvement in diagnosis rates of coeliac disease.

Loading posts...

« Previous 1 … 20 21 22